LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $356,000 | -58.1% | 2,620 | -15.3% | 0.23% | -49.7% |
| Q3 2018 | $850,000 | -27.4% | 3,095 | -50.8% | 0.46% | +40.5% |
| Q2 2018 | $1,171,000 | +125.6% | 6,290 | +100.0% | 0.33% | +12.6% |
| Q1 2018 | $519,000 | -39.8% | 3,145 | -50.0% | 0.29% | +25.1% |
| Q4 2017 | $862,000 | +5.5% | 6,290 | -0.8% | 0.24% | -2.1% |
| Q3 2017 | $817,000 | +112.2% | 6,340 | +100.0% | 0.24% | +4.3% |
| Q2 2017 | $385,000 | +14.6% | 3,170 | 0.0% | 0.23% | +11.7% |
| Q1 2017 | $336,000 | +4.3% | 3,170 | 0.0% | 0.21% | -4.2% |
| Q4 2016 | $322,000 | +1.3% | 3,170 | +1.6% | 0.22% | +0.5% |
| Q3 2016 | $318,000 | -8.6% | 3,120 | +6.8% | 0.21% | -9.3% |
| Q2 2016 | $348,000 | +12.6% | 2,920 | +1.0% | 0.24% | +9.3% |
| Q1 2016 | $309,000 | – | 2,890 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |